EGR1 c.298_300delinsATC ;(p.L100I)

Variant ID: 5-137801748-CTG-ATC

NM_001964.2(EGR1):c.298_300delinsATC;(p.L100I)

This variant was identified in 43 publications

View GRCh38 version.




Publications:


The immunopeptidome from a genomic perspective: Establishing the non-canonical landscape of MHC class I-associated peptides.

Cancer Immunology Research
Bedran, Georges G; Gasser, Hans-Christof HC; Weke, Kenneth K; Wang, Tongjie T; Bedran, Dominika D; Laird, Alexander A; Battail, Christophe C; Zanzotto, Fabio Massimo FM; Pesquita, Catia C; Axelson, Håkan H; Rajan, Ajitha A; Harrison, David J DJ; Palkowski, Aleksander A; Pawlik, Maciej M; Parys, Maciej M; O'Neill, J Robert JR; Brennan, Paul M PM; Symeonides, Stefan N SN; Goodlett, David R DR; Litchfield, Kevin K; Fahraeus, Robin R; Hupp, Ted R TR; Kote, Sachin S; Alfaro, Javier A JA
Publication Date: 2023-03-24

Variant appearance in text: 225: L100i
PubMed Link: 36961404
Variant Present in the following documents:
  • cir-22-0621_supplementary_table_5_suppst5.xlsx, sheet 1
View BVdb publication page



KLF3 and PAX6 are candidate driver genes in late-stage, MSI-hypermutated endometrioid endometrial carcinomas.

Plos One
Rudd, Meghan L ML; Hansen, Nancy F NF; Zhang, Xiaolu X; Urick, Mary Ellen ME; Zhang, Suiyuan S; Merino, Maria J MJ; , ; Mullikin, James C JC; Brody, Lawrence C LC; Bell, Daphne W DW
Publication Date: 2022

Variant appearance in text: 225: L100I
PubMed Link: 35081118
Variant Present in the following documents:
  • pone.0251286.s005.xlsx, sheet 6
View BVdb publication page



KLF3 and PAX6 are candidate driver genes in late-stage, MSI-hypermutated endometrioid endometrial carcinomas.

Plos One
Rudd, Meghan L ML; Hansen, Nancy F NF; Zhang, Xiaolu X; Urick, Mary Ellen ME; Zhang, Suiyuan S; Merino, Maria J MJ; , ; Mullikin, James C JC; Brody, Lawrence C LC; Bell, Daphne W DW
Publication Date: 2022

Variant appearance in text: 225: L100I
PubMed Link: 35081118
Variant Present in the following documents:
  • pone.0251286.s005.xlsx, sheet 6
View BVdb publication page



Risk Factors of Drug Resistance and the Potential Risk of HIV-1 Transmission of Patients with ART Virological Failure: A Population-Based Study in Sichuan, China.

Infection And Drug Resistance
Zhou, Chang C; Kang, Rui R; Liang, Shu S; Fei, Teng T; Li, Yiping Y; Su, Ling L; Li, Ling L; Ye, Li L; Zhang, Yan Y; Yuan, Dan D
Publication Date: 2021

Variant appearance in text: 225: L100I
PubMed Link: 34908855
Variant Present in the following documents:
  • Main text
  • idr-14-5219.pdf
View BVdb publication page



Drug Resistance in HIV-Positive Adults During the Initial Year of Antiretroviral Treatment at Ethiopian Health Centers.

Open Forum Infectious Diseases
Reepalu, Anton A; Arimide, Dawit A DA; Balcha, Taye T TT; Yeba, Habtamu H; Zewdu, Adinew A; Medstrand, Patrik P; Björkman, Per P
Publication Date: 2021-04

Variant appearance in text: 225: L100I
PubMed Link: 34805444
Variant Present in the following documents:
  • ofab106_suppl_Supplementary_Material.xlsx, sheet 2
  • ofab106_suppl_Supplementary_Material.xlsx, sheet 1
View BVdb publication page



Temporal Trends in HIV-1 Mutations Used for the Surveillance of Transmitted Drug Resistance.

Viruses
Rhee, Soo-Yon SY; Tzou, Philip L PL; Shafer, Robert W RW
Publication Date: 2021-05-11

Variant appearance in text: 225: L100I
PubMed Link: 34064774
Variant Present in the following documents:
  • Main text
  • viruses-13-00879.pdf
View BVdb publication page



HIV-1 transmitted drug resistance surveillance: shifting trends in study design and prevalence estimates.

Journal Of The International Aids Society
Rhee, Soo-Yon SY; Kassaye, Seble G SG; Barrow, Geoffrey G; Sundaramurthi, Jagadish Chandrabose JC; Jordan, Michael R MR; Shafer, Robert W RW
Publication Date: 2020-09

Variant appearance in text: 225: L100I
PubMed Link: 32936523
Variant Present in the following documents:
  • JIA2-23-e25611-s002.xlsx, sheet 1
View BVdb publication page



Clinical targeting of HIV capsid protein with a long-acting small molecule.

Nature
Link, John O JO; Rhee, Martin S MS; Tse, Winston C WC; Zheng, Jim J; Somoza, John R JR; Rowe, William W; Begley, Rebecca R; Chiu, Anna A; Mulato, Andrew A; Hansen, Derek D; Singer, Eric E; Tsai, Luong K LK; Bam, Rujuta A RA; Chou, Chien-Hung CH; Canales, Eda E; Brizgys, Gediminas G; Zhang, Jennifer R JR; Li, Jiayao J; Graupe, Michael M; Morganelli, Philip P; Liu, Qi Q; Wu, Qiaoyin Q; Halcomb, Randall L RL; Saito, Roland D RD; Schroeder, Scott D SD; Lazerwith, Scott E SE; Bondy, Steven S; Jin, Debi D; Hung, Magdeleine M; Novikov, Nikolai N; Liu, Xiaohong X; Villaseñor, Armando G AG; Cannizzaro, Carina E CE; Hu, Eric Y EY; Anderson, Robert L RL; Appleby, Todd C TC; Lu, Bing B; Mwangi, Judy J; Liclican, Albert A; Niedziela-Majka, Anita A; Papalia, Giuseppe A GA; Wong, Melanie H MH; Leavitt, Stephanie A SA; Xu, Yili Y; Koditek, David D; Stepan, George J GJ; Yu, Helen H; Pagratis, Nikos N; Clancy, Sheila S; Ahmadyar, Shekeba S; Cai, Terrence Z TZ; Sellers, Scott S; Wolckenhauer, Scott A SA; Ling, John J; Callebaut, Christian C; Margot, Nicolas N; Ram, Renee R RR; Liu, Ya-Pei YP; Hyland, Rob R; Sinclair, Gary I GI; Ruane, Peter J PJ; Crofoot, Gordon E GE; McDonald, Cheryl K CK; Brainard, Diana M DM; Lad, Latesh L; Swaminathan, Swami S; Sundquist, Wesley I WI; Sakowicz, Roman R; Chester, Anne E AE; Lee, William E WE; Daar, Eric S ES; Yant, Stephen R SR; Cihlar, Tomas T
Publication Date: 2020-08

Variant appearance in text: 225: L100I
PubMed Link: 32612233
Variant Present in the following documents:
  • Main text
View BVdb publication page



Prevalence and determinants of virological failure, genetic diversity and drug resistance among people living with HIV in a minority area in China: a population-based study.

Bmc Infectious Diseases
Yuan, Dan D; Liu, Meijing M; Jia, Peng P; Li, Yiping Y; Huang, Yuling Y; Ye, Li L; Api, Laze L; Chen, Maogang M; Yao, Liang L; Wang, Zixin Z; Liu, Honglu H; Liang, Shu S; Yang, Shujuan S
Publication Date: 2020-06-23

Variant appearance in text: 225: L100I
PubMed Link: 32576136
Variant Present in the following documents:
  • Main text
View BVdb publication page



Non-Nucleoside Reverse Transcriptase Inhibitors Join Forces with Integrase Inhibitors to Combat HIV.

Pharmaceuticals (Basel, Switzerland)
Himmel, Daniel M DM; Arnold, Eddy E
Publication Date: 2020-06-11

Variant appearance in text: 225: L100I
PubMed Link: 32545407
Variant Present in the following documents:
  • Main text
  • pharmaceuticals-13-00122.pdf
View BVdb publication page



Characterization of HIV-1 subtypes and drug resistance mutations in Henan Province, China (2017-2019).

Archives Of Virology
Yang, Zhaojie Z; Wei, Shuguang S; Liu, Jinjin J; Piao, Junyan J; Xu, Lixia L; Sun, Yan Y; Deng, Xin X; Yang, Xuan X; Liu, Chunli C; Ma, Shuhuan S; Zhao, Qingxia Q; Huo, Yuqi Y
Publication Date: 2020-06

Variant appearance in text: 225: L100I
PubMed Link: 32279138
Variant Present in the following documents:
  • Main text
  • 705_2020_Article_4606.pdf
View BVdb publication page



Analysis of HIV-1 diversity, primary drug resistance and transmission networks in Croatia.

Scientific Reports
Oroz, Maja M; Begovac, Josip J; Planinić, Ana A; Rokić, Filip F; Lunar, Maja M MM; Zorec, Tomaž Mark TM; Beluzić, Robert R; Korać, Petra P; Vugrek, Oliver O; Poljak, Mario M; Lepej, Snježana Židovec SŽ
Publication Date: 2019-11-21

Variant appearance in text: 225: L100I
PubMed Link: 31754119
Variant Present in the following documents:
  • Main text
  • 41598_2019_Article_53520.pdf
View BVdb publication page



Persistence of Human Immunodeficiency Virus-1 Drug Resistance Mutations in Proviral Deoxyribonucleic Acid After Virologic Failure of Efavirenz-Containing Antiretroviral Regimens.

Open Forum Infectious Diseases
De La Cruz, Justin J; Vardhanbhuti, Saran S; Sahoo, Malaya K MK; Rovner, Robert R; Bosch, Ronald J RJ; Manasa, Justen J; Katzenstein, David A DA; Pinsky, Benjamin A BA
Publication Date: 2019-03

Variant appearance in text: 225: L100I
PubMed Link: 30863788
Variant Present in the following documents:
  • Main text
  • ofz034.pdf
View BVdb publication page



Long-term virological outcome in children receiving first-line antiretroviral therapy.

Aids Research And Therapy
Chandrasekaran, Padmapriyadarsini P; Shet, Anita A; Srinivasan, Ramalingam R; Sanjeeva, G N GN; Subramanyan, Sudha S; Sunderesan, Suba S; Ramesh, Karunaianantham K; Gopalan, Bindu B; Suresh, Elumalai E; Poornagangadevi, Navaneethan N; Hanna, Luke E LE; Chandrasekar, Chockalingam C; Wanke, Christine C; Swaminathan, Soumya S
Publication Date: 2018-11-26

Variant appearance in text: 225: L100I
PubMed Link: 30477526
Variant Present in the following documents:
  • Main text
  • 12981_2018_Article_208.pdf
View BVdb publication page



Drug resistance outcomes of long-term ART with tenofovir disoproxil fumarate in the absence of virological monitoring.

The Journal Of Antimicrobial Chemotherapy
Villa, Giovanni G; Phillips, Richard O RO; Smith, Colette C; Stockdale, Alexander J AJ; Ruggiero, Alessandra A; Beloukas, Apostolos A; Appiah, Lambert T LT; Chadwick, David D; Sarfo, Fred S FS; Geretti, Anna Maria AM
Publication Date: 2018-11-01

Variant appearance in text: 225: L100I
PubMed Link: 30032305
Variant Present in the following documents:
  • Main text
  • dky281.pdf
View BVdb publication page



Raltegravir plus abacavir/lamivudine in virologically suppressed HIV-1-infected patients: 48-week results of the KIRAL study.

Plos One
Troya, Jesús J; Montejano, Rocio R; Ryan, Pablo P; Gómez, Cristina C; Matarranz, Mariano M; Cabello, Alfonso A; Vera, Francisco F; Sepúlveda, María Antonia MA; Santos, Ignacio I; Samperiz, Gloria G; Bachiller, Pablo P; Boix, Vicente V; Barrufet, Pilar P; Cervero, Miguel M; Sanz, José J; Solís, Javier J; Yllescas, María M; Valencia, Eulalia E; ,
Publication Date: 2018

Variant appearance in text: 225: L100I
PubMed Link: 29902204
Variant Present in the following documents:
  • Main text
  • pone.0198768.pdf
View BVdb publication page



Brazilian network for HIV Drug Resistance Surveillance (HIV-BresNet): a survey of treatment-naive individuals.

Journal Of The International Aids Society
Arruda, Monica B MB; Boullosa, Lídia T LT; Cardoso, Cynthia C CC; da Costa, Carolina M CM; Alves, Carlos Rb CR; de Lima, Shirlene Ts ST; Kaminski, Helena T HT; Aleixo, Agdemir W AW; Esposito, Ana Op AO; Cavalcanti, Ana Ms AM; Riedel, Maristela M; Couto-Fernandez, José C JC; Ferreira, Selma B SB; de Oliveira, Ivi Cm IC; Portal, Loreci E LE; Wolf, Hilda Hc HH; Fernandes, Sandra B SB; de M C Pardini, Maria I MI; Feiteiro, Manoel Vc MV; Tolentino, Fernanda M FM; Diaz, Ricardo S RS; Lopes, Giselle Isl GI; Francisco, Roberta Bl RB; Véras, Nazle Mc NM; Pires, Ana F AF; Franchini, Miriam M; Mesquita, Fábio F; Tanuri, Amilcar A; ,
Publication Date: 2018-03

Variant appearance in text: 225: L100I
PubMed Link: 29504269
Variant Present in the following documents:
  • JIA2-21-e25032.pdf
View BVdb publication page



Comparison of six methods to estimate adherence in an ART-naïve cohort in a resource-poor setting: which best predicts virological and resistance outcomes?

Aids Research And Therapy
Orrell, Catherine C; Cohen, Karen K; Leisegang, Rory R; Bangsberg, David R DR; Wood, Robin R; Maartens, Gary G
Publication Date: 2017-04-04

Variant appearance in text: 225: L100I
PubMed Link: 28376815
Variant Present in the following documents:
  • Main text
  • 12981_2017_Article_138.pdf
View BVdb publication page



Frequent Cross-Resistance to Dapivirine in HIV-1 Subtype C-Infected Individuals after First-Line Antiretroviral Therapy Failure in South Africa.

Antimicrobial Agents And Chemotherapy
Penrose, Kerri J KJ; Wallis, Carole L CL; Brumme, Chanson J CJ; Hamanishi, Kristen A KA; Gordon, Kelley C KC; Viana, Raquel V RV; Harrigan, P Richard PR; Mellors, John W JW; Parikh, Urvi M UM
Publication Date: 2017-02

Variant appearance in text: 225: L100I
PubMed Link: 27895013
Variant Present in the following documents:
  • Main text
View BVdb publication page



Antiviral Activity of Bictegravir (GS-9883), a Novel Potent HIV-1 Integrase Strand Transfer Inhibitor with an Improved Resistance Profile.

Antimicrobial Agents And Chemotherapy
Tsiang, Manuel M; Jones, Gregg S GS; Goldsmith, Joshua J; Mulato, Andrew A; Hansen, Derek D; Kan, Elaine E; Tsai, Luong L; Bam, Rujuta A RA; Stepan, George G; Stray, Kirsten M KM; Niedziela-Majka, Anita A; Yant, Stephen R SR; Yu, Helen H; Kukolj, George G; Cihlar, Tomas T; Lazerwith, Scott E SE; White, Kirsten L KL; Jin, Haolun H
Publication Date: 2016-12

Variant appearance in text: 225: L100I
PubMed Link: 27645238
Variant Present in the following documents:
  • AAC.01474-16_zac012165725so1.pdf
View BVdb publication page



HIV-1 Antiretroviral Drug Resistance Mutations in Treatment Naïve and Experienced Panamanian Subjects: Impact on National Use of EFV-Based Schemes.

Plos One
Mendoza, Yaxelis Y; Castillo Mewa, Juan J; Martínez, Alexander A AA; Zaldívar, Yamitzel Y; Sosa, Néstor N; Arteaga, Griselda G; Armién, Blas B; Bautista, Christian T CT; García-Morales, Claudia C; Tapia-Trejo, Daniela D; Ávila-Ríos, Santiago S; Reyes-Terán, Gustavo G; Bello, Gonzalo G; Pascale, Juan M JM
Publication Date: 2016

Variant appearance in text: 225: L100I
PubMed Link: 27119150
Variant Present in the following documents:
  • Main text
  • pone.0154317.pdf
View BVdb publication page



Rilpivirine analogs potently inhibit drug-resistant HIV-1 mutants.

Retrovirology
Smith, Steven J SJ; Pauly, Gary T GT; Akram, Aamir A; Melody, Kevin K; Rai, Ganesha G; Maloney, David J DJ; Ambrose, Zandrea Z; Thomas, Craig J CJ; Schneider, Joel T JT; Hughes, Stephen H SH
Publication Date: 2016-02-16

Variant appearance in text: 225: L100I
PubMed Link: 26880034
Variant Present in the following documents:
  • Main text
  • 12977_2016_Article_244.pdf
View BVdb publication page



Identification of Immunogenic Cytotoxic T Lymphocyte Epitopes Containing Drug Resistance Mutations in Antiretroviral Treatment-Naïve HIV-Infected Individuals.

Plos One
Blanco-Heredia, Juan J; Lecanda, Aarón A; Valenzuela-Ponce, Humberto H; Brander, Christian C; Ávila-Ríos, Santiago S; Reyes-Terán, Gustavo G
Publication Date: 2016

Variant appearance in text: 225: L100I
PubMed Link: 26808823
Variant Present in the following documents:
  • pone.0147571.s001.xlsx, sheet 1
View BVdb publication page



Population-based human immunodeficiency virus 1 drug resistance profiles among individuals who experienced virological failure to first-line antiretroviral therapy in Henan, China during 2010-2011.

Aids Research And Therapy
Liu, Jia J; Wu, Yasong Y; Yang, Wenjie W; Xue, Xiujuan X; Sun, Guoqing G; Liu, Chunhua C; Tian, Suian S; Sun, Dingyong D; Zhu, Qian Q; Wang, Zhe Z
Publication Date: 2015

Variant appearance in text: 225: L100I
PubMed Link: 26120348
Variant Present in the following documents:
  • Main text
View BVdb publication page



Current perspectives on HIV-1 antiretroviral drug resistance.

Viruses
Iyidogan, Pinar P; Anderson, Karen S KS
Publication Date: 2014-10-24

Variant appearance in text: 225: L100I
PubMed Link: 25341668
Variant Present in the following documents:
  • Main text
View BVdb publication page



The emerging profile of cross-resistance among the nonnucleoside HIV-1 reverse transcriptase inhibitors.

Viruses
Sluis-Cremer, Nicolas N
Publication Date: 2014-07-31

Variant appearance in text: 225: L100I
PubMed Link: 25089538
Variant Present in the following documents:
  • Main text
View BVdb publication page



Drug resistance in children at virological failure in a rural KwaZulu-Natal, South Africa, cohort.

Aids Research And Therapy
Pillay, Sureshnee S; Bland, Ruth M RM; Lessells, Richard J RJ; Manasa, Justen J; de Oliveira, Tulio T; Danaviah, Sivapragashini S
Publication Date: 2014-01-20

Variant appearance in text: 225: L100I
PubMed Link: 24444369
Variant Present in the following documents:
  • 1742-6405-11-3.pdf
View BVdb publication page



The Need for Development of New HIV-1 Reverse Transcriptase and Integrase Inhibitors in the Aftermath of Antiviral Drug Resistance.

Scientifica
Wainberg, Mark A MA
Publication Date: 2012

Variant appearance in text: 225: L100I
PubMed Link: 24278679
Variant Present in the following documents:
  • Main text
View BVdb publication page



Combination therapies, effectiveness, and adherence in patients with HIV infection: clinical utility of a single tablet of emtricitabine, rilpivirine, and tenofovir.

Hiv/Aids (Auckland, N.Z.)
Wainberg, Mark A MA
Publication Date: 2013

Variant appearance in text: 225: L100I
PubMed Link: 23413112
Variant Present in the following documents:
  • Main text
View BVdb publication page



Clinical, epidemiological and molecular features of the HIV-1 subtype C and recombinant forms that are circulating in the city of São Paulo, Brazil.

Virology Journal
Alcalde, Rosana R; Guimarães, Monick L ML; Duarte, Alberto J S AJ; Casseb, Jorge J
Publication Date: 2012-08-09

Variant appearance in text: 225: L100I
PubMed Link: 22877156
Variant Present in the following documents:
  • Main text
  • 1743-422X-9-156.pdf
View BVdb publication page



A Guide to HIV-1 Reverse Transcriptase and Protease Sequencing for Drug Resistance Studies.

Hiv Sequence Compendium
Shafer, Robert W RW; Dupnik, Kathryn K; Winters, Mark A MA; Eshleman, Susan H SH
Publication Date: 2001

Variant appearance in text: 225: L100I
PubMed Link: 22324021
Variant Present in the following documents:
  • Main text
View BVdb publication page



Role of etravirine in the management of treatment-experienced patients with human immunodeficiency virus type 1.

Hiv/Aids (Auckland, N.Z.)
Viani, Rolando M RM
Publication Date: 2010

Variant appearance in text: 225: L100I
PubMed Link: 22096392
Variant Present in the following documents:
  • Main text
View BVdb publication page



HIV-1 mutational pathways under multidrug therapy.

Aids Research And Therapy
Lawyer, Glenn G; Altmann, André A; Thielen, Alexander A; Zazzi, Maurizio M; Sönnerborg, Anders A; Lengauer, Thomas T
Publication Date: 2011-07-27

Variant appearance in text: 225: L100I
PubMed Link: 21794106
Variant Present in the following documents:
  • Main text
  • 1742-6405-8-26.pdf
View BVdb publication page



Constrained patterns of covariation and clustering of HIV-1 non-nucleoside reverse transcriptase inhibitor resistance mutations.

The Journal Of Antimicrobial Chemotherapy
Reuman, Elizabeth C EC; Rhee, Soo-Yon SY; Holmes, Susan P SP; Shafer, Robert W RW
Publication Date: 2010-07

Variant appearance in text: 225: L100I
PubMed Link: 20462946
Variant Present in the following documents:
  • Main text
View BVdb publication page



Viremia and drug resistance among HIV-1 patients on antiretroviral treatment: a cross-sectional study in Soweto, South Africa.

Aids (London, England)
El-Khatib, Ziad Z; Ekstrom, Anna Mia AM; Ledwaba, Johanna J; Mohapi, Lerato L; Laher, Fatima F; Karstaedt, Alan A; Charalambous, Salome S; Petzold, Max M; Katzenstein, David D; Morris, Lynn L
Publication Date: 2010-07-17

Variant appearance in text: 225: L100I
PubMed Link: 20453629
Variant Present in the following documents:
  • Main text
View BVdb publication page



The M230L nonnucleoside reverse transcriptase inhibitor resistance mutation in HIV-1 reverse transcriptase impairs enzymatic function and viral replicative capacity.

Antimicrobial Agents And Chemotherapy
Xu, Hong-Tao HT; Quan, Yudong Y; Schader, Susan M SM; Oliveira, Maureen M; Bar-Magen, Tamara T; Wainberg, Mark A MA
Publication Date: 2010-06

Variant appearance in text: 225: L100I
PubMed Link: 20308384
Variant Present in the following documents:
  • Main text
View BVdb publication page



The Genetic Basis of HIV-1 Resistance to Reverse Transcriptase and Protease Inhibitors.

Aids Reviews
Shafer, Robert W RW; Kantor, Rami R; Gonzales, Matthew J MJ
Publication Date: 2000

Variant appearance in text: 225: L100I
PubMed Link: 19096725
Variant Present in the following documents:
  • Main text
View BVdb publication page



Crystal engineering of HIV-1 reverse transcriptase for structure-based drug design.

Nucleic Acids Research
Bauman, Joseph D JD; Das, Kalyan K; Ho, William C WC; Baweja, Mukta M; Himmel, Daniel M DM; Clark, Arthur D AD; Oren, Deena A DA; Boyer, Paul L PL; Hughes, Stephen H SH; Shatkin, Aaron J AJ; Arnold, Eddy E
Publication Date: 2008-09

Variant appearance in text: 225: L100I
PubMed Link: 18676450
Variant Present in the following documents:
  • gkn464.pdf
View BVdb publication page



HIV-1 drug resistance mutations: an updated framework for the second decade of HAART.

Aids Reviews
Shafer, Robert W RW; Schapiro, Jonathan M JM
Publication Date: 2008

Variant appearance in text: 225: L100I
PubMed Link: 18615118
Variant Present in the following documents:
  • Main text
View BVdb publication page



Genotypic predictors of human immunodeficiency virus type 1 drug resistance.

Proceedings Of The National Academy Of Sciences Of The United States Of America
Rhee, Soo-Yon SY; Taylor, Jonathan J; Wadhera, Gauhar G; Ben-Hur, Asa A; Brutlag, Douglas L DL; Shafer, Robert W RW
Publication Date: 2006-11-14

Variant appearance in text: 225: L100I
PubMed Link: 17065321
Variant Present in the following documents:
  • Main text
View BVdb publication page



Relative replication fitness of efavirenz-resistant mutants of HIV-1: correlation with frequency during clinical therapy and evidence of compensation for the reduced fitness of K103N + L100I by the nucleoside resistance mutation L74V.

Virology
Koval, Christine E CE; Dykes, Carrie C; Wang, Jiong J; Demeter, Lisa M LM
Publication Date: 2006-09-15

Variant appearance in text: 225: L100I
PubMed Link: 16797050
Variant Present in the following documents:
  • Main text
View BVdb publication page



HIV-1 Protease and reverse-transcriptase mutations: correlations with antiretroviral therapy in subtype B isolates and implications for drug-resistance surveillance.

The Journal Of Infectious Diseases
Rhee, Soo-Yon SY; Fessel, W Jeffrey WJ; Zolopa, Andrew R AR; Hurley, Leo L; Liu, Tommy T; Taylor, Jonathan J; Nguyen, Dong Phuong DP; Slome, Sally S; Klein, Daniel D; Horberg, Michael M; Flamm, Jason J; Follansbee, Stephen S; Schapiro, Jonathan M JM; Shafer, Robert W RW
Publication Date: 2005-08-01

Variant appearance in text: 225: L100I
PubMed Link: 15995959
Variant Present in the following documents:
  • Main text
View BVdb publication page



Sources and magnitude of intralaboratory variability in a sequence-based genotypic assay for human immunodeficiency virus type 1 drug resistance.

Journal Of Clinical Microbiology
Galli, R A RA; Sattha, B B; Wynhoven, B B; O'Shaughnessy, M V MV; Harrigan, P R PR
Publication Date: 2003-07

Variant appearance in text: 225: L100I
PubMed Link: 12843019
Variant Present in the following documents:
  • Main text
View BVdb publication page



Genotypic testing for human immunodeficiency virus type 1 drug resistance.

Clinical Microbiology Reviews
Shafer, Robert W RW
Publication Date: 2002-04

Variant appearance in text: 225: L100I
PubMed Link: 11932232
Variant Present in the following documents:
  • Main text
View BVdb publication page